eRegulatory: Empowering Sites to do More with Less (Paper)
Clinical research sites are facing increasing competition to win studies and higher levels of administrative burden than ever before. eRegulatory and eISF systems offer a solution to save time, cut costs, and ultimately manage more trials.
Watch this on-demand webinar to learn best practices for adopting eRegulatory to increase efficiency, improve compliance, and grow study capacity.
- Review the time-saving and cost-reduction benefits of eRegulatory
- Discover how the right systems will improve your relationship with Sponsors and monitors
- Best Practices to overcome the most common barriers to adopting eRegulatory
Doug Schantz, Executive Director of Clinical Operations, AstraZeneca
Doug Schanz is responsible for US site management and monitoring, risk-based quality management implementation and late-phase CRO outsourcing. Prior to AstraZeneca in 2015, Doug worked at Pfizer for 17 years and Eli Lilly previously for 8 years. Doug started his career as a study coordinator at a group of urgent care centers in central New Jersey.
Dr. Jeff Kingsley, Founder and CEO, IACT Health
Dr. Jeff Kingsley is the founder and CEO of IACT Health, a research management organization, and 15 wholly owned and integrated clinical research offices throughout the Southeastern United States. The family of companies conduct phase Ib through IV research in nearly every medical specialty; inpatient and outpatient; pharmaceutical, biotechnology, and medical device. He has dedicated his career to clinical research since 2006. He enjoys each day with his wife Christine and four beautiful children.
Jason Methia, VP, Site Engagement and eTMF Strategy
Jason Methia is accountable for Veeva’s overall site technology strategy. Prior to joining Veeva in 2013, Jason held a variety of roles within cliinical development at the Dana Farber Cancer Institute, Wyeth Research and Vertex Pharmaceuticals. Jason received his MS in drug development and regulatory affairs from Northeastern University and his BA in psychology from the University of Vermont.